02:26:29 EDT Wed 06 May 2026
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Precision Peptide company Inc (The)
Symbol BPC
Shares Issued 45,714,307
Close 2026-05-05 C$ 0.51
Market Cap C$ 23,314,297
Recent Sedar+ Documents

Precision Peptide receives $1.3M from warrant exercise

2026-05-05 18:35 ET - News Release

Mr. Pratap Sandhu reports

C$1.3 MILLION IN PROCEEDS RECEIVED BY THE PRECISION PEPTIDE COMPANY FROM WARRANT EXERCISES

The Precision Peptide Company Inc. has received approximately $1.3-million from the exercise of outstanding warrants.

The proceeds strengthen the company's balance sheet and will be used to support the continued development and expansion of its Amino Innovations platform, including product rollout, delivery technology advancement and distribution growth across North America.

BPC is focused on addressing a key limitation within the peptide category: delivery. While demand for peptide-based wellness solutions continues to grow, traditional formats have restricted broader adoption. The company's approach centres on transdermal and oral delivery systems, including its developing peptide patch platform, designed to improve convenience and accessibility.

With products manufactured in an approved United States facility and a growing North American distribution footprint, BPC continues to position itself at the intersection of scientific formulation and scalable consumer wellness.

Pratap Sandhu, chief executive officer of Precision Peptide, commented: "These proceeds are particularly well timed. The regulatory landscape around peptides is evolving toward greater clarity and science-based standards. We believe this will favour credible operators with quality manufacturing and differentiated delivery technology, areas where BPC has invested deliberately. The capital received strengthens our ability to execute on that positioning and accelerate our pipeline and distribution buildout."

About The Precision Peptide Company Inc.

The Precision Peptide is a publicly traded wellness company building a next-generation platform for high-quality peptide formulations. By combining scientific formulation and innovative delivery technologies, the company creates products at the intersection of biotechnology and scalable consumer wellness. Products are manufactured in an approved U.S. facility and distributed across North America.

We seek Safe Harbor.

© 2026 Canjex Publishing Ltd. All rights reserved.